Kashyap Tele Medicines Ltd Stock Price Today (NSE: KASHYAP)
Fundamental Score
Kashyap Tele Medicines Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Kashyap Tele Medicines Ltd share price today is ₹5.04, up +0.00% on NSE/BSE as of 30 March 2026. Kashyap Tele Medicines Ltd (KASHYAP) is a Small-cap company in the IT Enabled Services sector with a market capitalisation of ₹45.19 (Cr). The 52-week high for KASHYAP share price is ₹12.50 and the 52-week low is ₹4.20. 0
Kashyap Tele Medicines Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Kashyap Tele Medicines Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Kashyap Tele Medicines Share Price Analysis: A ROCE Efficiency Perspective
In the dynamic IT-Enabled Services (ITES) sector, characterized by rapid technological advancements and evolving customer demands, Return on Capital Employed (ROCE) serves as a crucial indicator of a company’s efficiency in utilizing capital to generate profits. This analysis focuses on Kashyap Tele Medicines share price (₹6.19) through the lens of ROCE, a key metric for assessing financial performance. This assessment is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra.
Currently, Kashyap Tele Medicines Ltd. reports a ROCE of 0.0%. This figure raises concerns about the company's profitability relative to the capital invested in the business. A low ROCE suggests the company may not be effectively deploying its assets to generate returns, potentially indicating inefficiencies in operations, high operating costs, or low revenue generation. Comparing this with sector peers highlights the discrepancy.
FCS Software Solutions Ltd, for instance, might exhibit different management approaches which impact the perceived quality of the leadership and their ability to deploy capital effectively. Ultimately, management effectiveness strongly influences the success of an ITES company.The absence of a Price-to-Earnings (PE) ratio further complicates the analysis, potentially indicating the company isn’t profitable or has negative earnings. In contrast, peers like Euphoria Infotech India Ltd and Protean eGov Technologies Ltd may have positive PE ratios, providing a benchmark for comparison within the ITES landscape. A robust ROCE generally contributes to a stronger competitive moat, reflecting the company's ability to sustain profitability and fend off competition. A 0.0% ROCE, however, suggests a weak or non-existent moat. Competitors could potentially offer similar services at lower prices or with greater efficiency, eroding Kashyap Tele Medicines Ltd's market position.
The ITES sector rewards companies that can effectively leverage technology and human capital to deliver value-added services. Continuous monitoring of financial ratios, particularly ROCE, is essential for understanding the long-term sustainability and growth potential of companies operating within this sector. It will be critical to observe how Kashyap Tele Medicines Ltd. addresses its ROCE challenges and whether strategic changes are implemented to improve capital efficiency and overall financial health.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Kashyap Tele Medicines Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of KASHYAP across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (61.93%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (0.00%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.00%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-13.40%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-1.02% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Negative Free Cash Flow (₹-0.10 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.06%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Kashyap Tele Medicines Ltd Financial Statements
Comprehensive financial data for Kashyap Tele Medicines Ltd including income statement, balance sheet and cash flow
About KASHYAP (Kashyap Tele Medicines Ltd)
Kashyap Tele Medicines Ltd is a pioneering force in the Indian IT-Enabled Services sector, dedicated to revolutionizing healthcare accessibility and efficiency through innovative t...echnology solutions. We specialize in developing and deploying cutting-edge telemedicine platforms, enabling remote consultations, diagnostics, and patient monitoring. Our core competency lies in seamlessly integrating complex medical data with user-friendly interfaces, ensuring both healthcare professionals and patients can navigate the system with ease. Beyond the virtual consultation room, we offer comprehensive data analytics services, empowering healthcare providers with actionable insights to optimize resource allocation, improve treatment outcomes, and proactively manage population health. We are committed to bridging the geographical divide and democratizing access to quality healthcare for all. Our service portfolio encompasses a broad spectrum of technology solutions tailored to the unique needs of the healthcare industry. We provide secure and compliant data storage and management systems, adhering to the highest standards of patient privacy and data integrity. Our software development team is adept at creating custom applications for various medical specialties, streamlining workflows, and enhancing clinical decision support. We also offer robust IT infrastructure management, ensuring the seamless operation of healthcare facilities and minimizing disruptions to patient care. Moreover, we provide comprehensive training programs for healthcare professionals, equipping them with the skills and knowledge necessary to effectively utilize our telemedicine platforms and embrace the digital transformation of healthcare. Kashyap Tele Medicines Ltd is driven by a singular vision: to transform healthcare delivery through technology. We are committed to continuous innovation, constantly exploring new possibilities to enhance the effectiveness, efficiency, and accessibility of healthcare services. We foster a collaborative environment, bringing together a team of talented IT professionals, medical experts, and business strategists to develop and deploy impactful solutions. By leveraging the power of IT, we strive to empower healthcare providers, improve patient outcomes, and ultimately build a healthier and more equitable future for all. Our focus remains steadfast on delivering reliable, secure, and scalable telemedicine solutions that make a tangible difference in the lives of people across India and beyond.
Company Details
Key Leadership
Latest News
KASHYAP Share Price: Frequently Asked Questions
What is the current share price of Kashyap Tele Medicines Ltd (KASHYAP)?
As of 30 Mar 2026, 12:02 pm IST, Kashyap Tele Medicines Ltd share price is ₹5.04. The KASHYAP stock has a market capitalisation of ₹45.19 (Cr) on NSE/BSE.
Is KASHYAP share price Overvalued or Undervalued?
KASHYAP share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 33.81x. Based on this relative valuation, the Kashyap Tele Medicines Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of KASHYAP share price?
The 52-week high of KASHYAP share price is ₹12.50 and the 52-week low is ₹4.20. These values are updated daily from NSE/BSE price data.
What factors affect the Kashyap Tele Medicines Ltd share price?
Key factors influencing KASHYAP share price include quarterly earnings growth (Sales Growth: -100.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Kashyap Tele Medicines Ltd a good stock for long-term investment?
Kashyap Tele Medicines Ltd shows a 5-year Profit Growth of N/A% and an ROE of 0.00%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in KASHYAP shares.
How does Kashyap Tele Medicines Ltd compare with its industry peers?
Kashyap Tele Medicines Ltd competes with major peers in the IT Enabled Services. Investors should compare KASHYAP share price P/E of 0.00x and ROE of 0.00% against the industry averages to determine competitive standing.
What is the P/E ratio of KASHYAP and what does it mean?
KASHYAP share price has a P/E ratio of N/Ax compared to the industry average of 33.81x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is KASHYAP performing according to Bull Run's analysis?
KASHYAP has a Bull Run fundamental score of 8/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does KASHYAP belong to?
KASHYAP operates in the IT Enabled Services industry. This classification helps understand the competitive landscape and sector-specific trends affecting Kashyap Tele Medicines Ltd share price.
What is Return on Equity (ROE) and why is it important for KASHYAP?
KASHYAP has an ROE of 0.00%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Kashyap Tele Medicines Ltd generates profits from shareholders capital.
How is KASHYAP debt-to-equity ratio and what does it indicate?
KASHYAP has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.
What is KASHYAP dividend yield and is it a good dividend stock?
KASHYAP offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Kashyap Tele Medicines Ltd shares.
How has KASHYAP share price grown over the past 5 years?
KASHYAP has achieved 5-year growth rates of: Sales Growth -1.02%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in KASHYAP and why does it matter?
Promoters hold 61.93% of KASHYAP shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Kashyap Tele Medicines Ltd.
What is KASHYAP market capitalisation category?
KASHYAP has a market capitalisation of ₹45 crores, placing it in the Small-cap category.
How volatile is KASHYAP stock?
KASHYAP has a beta of N/A. A beta > 1 suggests the Kashyap Tele Medicines Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is KASHYAP operating profit margin trend?
KASHYAP has a 5-year average Operating Profit Margin (OPM) of -13.40%, indicating the company's operational efficiency.
How is KASHYAP quarterly performance?
Recent quarterly performance shows Kashyap Tele Medicines Ltd YoY Sales Growth of -100.00% and YoY Profit Growth of N/A%.
What is the institutional holding pattern in KASHYAP?
KASHYAP has FII holding of 0.00% and DII holding of 0.06%. Significant institutional holding often suggests professional confidence in the Kashyap Tele Medicines Ltd stock.